Open AccessBrief Report: Weight Gain Following ART Initiation in ART-Naïve People Living With HIV in the Current Treatment Era
Author(s) -
Stephanie A Ruderman,
Heidi M. Crane,
Robin M. Nance,
Bridget M. Whitney,
Barbara N Harding,
Kenneth H. Mayer,
Richard D. Moore,
Joseph J. Eron,
Elvin Geng,
W. Christopher Mathews,
Benigno Rodrı́guez,
Amanda Willig,
Greer Burkholder,
Sara Lindström,
Brian Wood,
Ann C. Collier,
Vani Vannappagari,
Cassidy Henegar,
Jean van Wyk,
Lloyd Curtis,
Michael S. Saag,
Mari M. Kitahata,
Joseph A. Delaney
Publication year - 2021
Publication title -
journal of acquired immune deficiency syndromes
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.162
H-Index - 157
eISSN - 1944-7884
pISSN - 1525-4135
DOI - 10.1097/qai.0000000000002556
Subject(s) - dolutegravir , efavirenz , regimen , medicine , abacavir , darunavir , tenofovir alafenamide , emtricitabine , weight change , raltegravir , weight loss , human immunodeficiency virus (hiv) , viral load , virology , antiretroviral therapy , obesity
Evaluate differences in weight change by regimen among people living with HIV (PLWH) initiating antiretroviral therapy (ART) in the current era.